Blueprint Medicines Corp (BPMC)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$98.00

Buy

$106.00

arrow-up$5.39 (+5.43%)

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. Its drug candidates include avapritinib, BLU 554, BLU-782 and BLU-667.
Prices updated at 03 May 2025, 00:38 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-up1.51%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
To view this unique content please
log in or open an account
Prices shown are in the currency of the stock selected. For example, if a UK stock is chosen these figures are in sterling, if a US stock chosen then the figures shown are in dollars.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.